The effects of an adenovirus-mediated Bcl-X L expression, driven by a neuron-specific human synapsin-1 promoter, on the degree of injury, were examined after transient focal ischemia in mice. Therefore, injections of vehicle, of an adenoviral E1-deleted control vector (Ad-dE1), or a Bcl-X L vector (Ad-Syn-Bcl-X L ) were stereotactically made in the striatum. Seven days later, focal ischemia was induced either by 30 min or 2 h of intraluminal thread occlusion. In line with previous data, 30 min of middle cerebral artery (MCA) occlusion reproducibly resulted in disseminated neuronal injury of the striatum, as revealed by cresyl violet and TUNEL 3 days after ischemia. The degree of cell injury was significantly reduced in Ad-Syn-Bcl-X L treated as compared with Ad-dE1 and vehicle-treated animals. On the other hand, 2 h of MCA occlusion produced reproducible infarcts both in vehicle and Ad-dE1 treated animals 24 h after ischemia. The infarct area at the level of the striatum was significantly decreased by Ad-Syn-Bcl-X L treatment. The present data demonstrate that an adenoviral Bcl-X L expression with a neuron-specific synapsin-1 promoter provides a powerful tool, which not only diminishes disseminated neuronal injury, but also protects against tissue infarction. © 2002 Elsevier Science (USA)
INTRODUCTION
The mechanisms of injury after focal ischemia critically depend on the duration of an ischemic insult. Longer-lasting episodes, as induced by middle cerebral artery (MCA) occlusions of Ն1 h duration in mice, may be associated with a restitution of the cerebral energy state immediately after reperfusion (Hata et al., 2000) . Yet, this restitution is only a temporary one and is succeeded by a secondary deterioration of metabolism, reflecting delayed tissue infarction (Hata et al., 2000) . Short ischemic episodes, on the other hand, as induced by MCA occlusions of Ͻ1 h, are followed by a persisting recovery of energy state, but may cause disseminated neuronal injury via activation of apoptotic programs (Hermann et al., 2001a) . These observations demonstrate that necrotic and apoptotic mechanisms may coexist after a stroke (Hermann et al., 2001a) . Accordingly, promising therapeutic strategies should protect against both kinds of changes.
Bcl-X L is a survival-promoting member of the Bcl-2 family of proteins, which play a critical role in the
